Healthcare
cold chain logistics comprises transportation and distribution of
pharmaceutical products which are temperature-sensitive. It helps the
healthcare industry in several ways such as increase the shelf life of numerous
medicines and ensure uninterrupted supply of equipment, medicines, and devices
from suppliers & distributors to different locations.
According
to study, “Healthcare
Cold Chain Logistics Market Information by Product type (Biopharmaceuticals,
Vaccines, Clinical Trial Materials and Others), Services (Storage,
Transportation, Packaging and Others), Storage Techniques (Electrical
refrigeration, Dry Ice, Gel Packs, Liquid nitrogen and Others), By Region
(North America, Europe, Asia Pacific, The Middle East & Africa (MEA) and
Latin America) - Global Forecast by 2023” the key companies operating
in the healthcare cold chain logistics market are DB Schenker, FedEx, American
Airlines, Inc., Marken, Cavalier Logistics, KUEHNE + NAGEL, DHL international
GmbH, AmerisourceBergen Corporation, Agility, Biotec Services International,
Air Canada Cargo, Biocair International, Avinex Ukr, Continental Air Cargo,
CEVA, Igloo Thermo-Logistics, Cold Chain Technologies, L&M Transportation
Services, CSafe Global, Nordic Cold Storage, Helapet, Panalpina World Transport,
Kerry Logistics, LifeConEx, Kuehne + Nagel International, VersaCold, Sofrigam,
World Courier Management, UTi Pharma, TNT Express.
Based
on product type, healthcare cold chain logistics market is segmented into
biopharmaceuticals, clinical trial materials, vaccines and others.
Biopharmaceuticals are usually complex protein molecules and their efficacy
requires temperature definite logistics. Vaccines segment is estimated to
witness lucrative growth owing to mass immunization programs conducted by various
government & non-government organizations during the forecast period. Based
on services, market is segmented into storage, packaging, transportation and
others. Based on mode of transportation, market is segmented into air, ground,
and ocean. Based on holding temperature range, market is segmented into
ambient, frozen, refrigerated, and deep frozen / cryogenic. Based on storage
techniques, market is segmented into dry ice, electrical refrigeration, liquid
nitrogen, gel packs, and others. Based on container type, market is segmented
into active containers and passive containers. In addition, based on end-user,
market is segmented into research institutes, biopharmaceutical companies,
hospitals & clinics, and others.
The
healthcare cold chain logistics market is driven by growth in transportation of
temperature-sensitive pharmaceutical products via cold chain logistics, rise in
number of clinical trials, increase in preference for personalized drugs by
large patient pool, and increase in pharmaceutical sector. However, high
operational cost and lack of standardization may impact the market. Moreover,
growth in technological advancements in cold chain logistics is a key
opportunities for market.
Recently,
governmental & non-governmental organizations are focusing on providing
healthcare facilities in the underdeveloped regions. Initiatives for instance
mass immunization, which requires vaccines stored in the temperature-controlled
chambers, in numerous developing & underdeveloped regions are generating demand
for cold chain logistics for transportation of temperature-sensitive
medications, leading to the growth of the global healthcare cold chain
logistics market.
Based
on geography, the North-American region holds major share in healthcare cold
chain logistics market owing to existence of a vast pharmaceutical
manufacturing sector and presence of large number of service providers in the
region. The European and Asian-Pacific regions are expected to witness higher
growth rate due to rapidly growth in geriatric population, various government
initiatives to take corrective actions in emerging economies and growth in
demand for biopharmaceutical products over the forecast period. It is projected
that the market will be reached at rapid pace as a result of rise in research
in the field of molecular biotechnology and widespread stem cell research
during the forecast period. The market is anticipated to reach a market share
of US $16,588.3 million by the year 2023.
To know more, click on
the link below:-
Contact Us:-
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
No comments:
Post a Comment